The discovery of the NMO-IgG antibody which was found to target the aquaporin-4 water channel (AQP4), did not only provide a reliable biomarker for the diagnosis of NMO, but also helped in the understanding of the disease process [6,7,8]. This evidence concerns the gene AQP4 and neuromyelitis optica.